News stories about China Nepstar Chain Drugstore (NYSE:NPD) have been trending positive recently, Alpha One Sentiment Analysis reports. The research firm, a division of Accern, rates the sentiment of news coverage by reviewing more than twenty million blog and news sources. Alpha One ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. China Nepstar Chain Drugstore earned a daily sentiment score of 0.31 on Alpha One’s scale. Alpha One also gave media stories about the company an impact score of 100 out of 100, indicating that recent news coverage is extremely likely to have an effect on the stock’s share price in the near term.

Shares of China Nepstar Chain Drugstore (NPD) traded up 0.39% on Friday, reaching $2.55. 227,194 shares of the company’s stock traded hands. China Nepstar Chain Drugstore has a 52 week low of $2.00 and a 52 week high of $2.59. The stock’s 50-day moving average price is $2.47 and its 200-day moving average price is $2.40.

WARNING: This report was reported by Financial Market News and is the sole property of of Financial Market News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at

About China Nepstar Chain Drugstore

China Nepstar Chain Drugstore Ltd. is a retail drugstore chain in China. The Company provides its customers with pharmacy services and a range of other merchandise, including over-the-counter drugs, nutritional supplements, herbal products, personal care products, family care products, as well as convenience products, including consumable, seasonal and promotional items.

Receive News & Ratings for China Nepstar Chain Drugstore Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Nepstar Chain Drugstore Ltd. and related companies with's FREE daily email newsletter.